Growth Metrics

Dexcom (DXCM) Other Non-Current Liabilities (2016 - 2026)

Dexcom has reported Other Non-Current Liabilities over the past 17 years, most recently at $141.8 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 5.66% to $141.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $141.8 million through Mar 2026, down 5.66% year-over-year, with the annual reading at $137.1 million for FY2025, 7.3% down from the prior year.
  • Other Non-Current Liabilities was $141.8 million for Q1 2026 at Dexcom, up from $137.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $151.6 million in Q2 2025 and troughed at $97.1 million in Q1 2022.
  • The 5-year median for Other Non-Current Liabilities is $129.7 million (2023), against an average of $131.4 million.
  • Year-over-year, Other Non-Current Liabilities soared 42.56% in 2022 and then fell 7.3% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $128.3 million in 2022, then dropped by 2.1% to $125.6 million in 2023, then grew by 17.75% to $147.9 million in 2024, then decreased by 7.3% to $137.1 million in 2025, then rose by 3.43% to $141.8 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Other Non-Current Liabilities are $141.8 million (Q1 2026), $137.1 million (Q4 2025), and $147.4 million (Q3 2025).